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proteins, which play a crucial role in B and T cell develop-antagonizes IFN- production in differentiating T cells,
ment (Engel and Murre, 2001). Overexpression of Id pro-GATA-3-deficient NK cells paradoxically produced
teins promotes NK cell development at the expenseless IFN- compared to control NK cells and failed to
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Listeria monocytogenes. Surprisingly, GATA-3 was es- Yokota et al., 1999). These data suggest that Id2 may
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Natural killer (NK) cells are a distinct subset of lympho- The further understanding of the transcriptional regula-
cytes that have the capacity to produce a battery of tion of NK cells may help to define discrete stages in
cytokines and kill tumor cells without prior sensitization NK cell differentiation and provide clues as to the
(reviewed in Trinchieri, 1989). NK cells play a role in “checkpoints” which operate during this process.
innate immunity by monitoring cellular expression of Nine members of the GATA family of transcription
major histocompatibility complex (MHC) class I mole- factors have been identified (Orkin, 1992; Laverriere et
cules, and eliminating cells that have abnormal MHC al., 1994), which are evolutionarily conserved and linked
expression due to viral infections or transformation (re- to embryonic tissue specification. Several GATA family
members (GATA-1, -2, and -3) are expressed in the he-
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bryonic brain and in the sympathetic nervous system T cells (Akashi et al., 2000; Hendriks et al., 1999; Ouyang
et al., 1998). Within the NK lineage, GATA-3 expression(George et al., 1994; Manaia et al., 2000). In the hemato-
poietic system, GATA-3 expression has been detected has been documented in both immature NK precursors
and mature splenic CD3NK1.1 NK cells (Biassoni etin hematopoietic stem cells (HSC), CLP, pro- and pre-T
cells, and polarized T helper-type 2 (Th2) CD4 cells al., 1993; Rosmaraki et al., 2001). To assess the role of
GATA-3 in NK cell differentiation, we generated hema-(Akashi et al., 2000; Ouyang et al., 1998). Two indepen-
dent mouse strains carrying GATA-3 null mutations have topoietic chimeras by injecting GATA-3-deficient
(GATA-3) embryonic HSC into alymphoid recipientbeen generated (Pandolfi et al., 1995; Ting et al., 1996).
GATA-3-deficient (GATA-3) embryos die during early hosts (mice double deficient in Rag and the common
cytokine receptor  chain: Ragc; Colucci et al., 2001).development (around embryonic day 11, E11), partially
due to reduced noradrenaline levels in the sympathetic These conditions allow the cell autonomous role of dif-
ferent TFs in lymphoid development, and particularlynervous system with resultant cardiac failure (Lim et al.,
2000). Concerning hematopoietic development, Ting et the NK lineage, to be assessed.
Since GATA-3 gene disruption causes early embry-al. demonstrated that T cell development is abrogated
in the absence of GATA-3 at an early CD4CD8 thymo- onic lethality (at about E11; Pandolfi et al., 1995; Ting
et al., 1996), our initial studies used wild-type (wt) andcyte precursor stage, whereas B cell and myeloid cell
development were unaffected by GATA-3 disruption GATA-3 Aorta-gonad-mesonephros (AGM; reviewed in
Godin and Cumano, 2002) derived from E10.5 embryos(Ting et al., 1996). The molecular mechanism responsible
for the GATA-3 block in T cell development is not known. as a source of donor HSC (Table 1) to generate hemato-
poietic chimeras. Consistent with previous reports (TingGATA-3 also plays an essential role in T cell differenti-
ation, whereby it acts to promote the generation of a et al., 1996), mature B cells could be normally generated
in absence of GATA-3, whereas T cell developmentsubset of CD4 T cells specialized in the production of
T helper 2 (Th2)-type cytokines (Zhang et al., 1997; was completely abrogated. We found that splenic
CD3NK1.1 NK cells were equally present in both wtZheng and Flavell, 1997). Two broad subsets of Th cells
have been described which differ in their cytokine pro- and GATA-3 chimeras (wt: 0.490.43106 cells versus
GATA-3: 0.34  0.44  106 cells; n  8 for each geno-duction profiles: Th1 T cells are generated following
infection by various intracellular pathogens and are po- type). However, generating AGM-derived chimeras re-
quired extensive numbers of embryos (three donor AGMlarized for production of IFN-. In contrast, Th2 cells
appear following infection with extracellular pathogens per recipient). In order to study a larger, more homoge-
neous cohort of chimeras, we used a technique allowing(such as parasites) and in allergic responses where they
produce predominantly IL-4, IL-5, and IL-13 (reviewed partial rescue of GATA-3 embryonic lethality (Lim et
al., 2000).in Glimcher and Murphy, 2000; Ho and Glimcher, 2002).
While initially described for CD4 T cells, several reports GATA-3 deficiency causes a reduction in tyrosine hy-
droxylase and dopamine -hydroxylase within sympa-have suggested that specialized cytokine-producing
subsets of CD8 T cells and NK cells exist (Colonna, thetic neurons, resulting in noradrenaline deficiency
(Lim et al., 2000). By providing pregnant dams with exog-2001). The distinct cytokine profiles of Th1 and Th2 cells
are controlled transcriptionally, and specific TF have enous catecholamine intermediates, development in
GATA-3 embryos can reach E16 (Lim et al., 2000). Usingbeen identified that appear to play a role in the initiation
or maintenance of this process. Th1 production by CD4 this approach, we recovered viable E12.5 GATA-3 em-
bryos (although only 6%; 32 out of a total of 513 em-T cells and NK cells requires T-bet, whereas GATA-3
and c-maf act to promote Th2 cytokine production by bryos; Table 1). The total cellularity of the fetal liver at
this stage was reduced in GATA-3 embryos (wt: 1.0 CD4 T cells (Szabo et al., 2000, 2002; Zhang et al.,
1997; Zheng and Flavell, 1997). T-bet and GATA-3 ex- 0.9  106 cells versus GATA-3: 0.4  0.35  106 cells;
n  32 for each genotype; p  0.007), although theirpression in Th subsets are generally mutually exclusive,
and these TFs may act to reciprocally repress each capacity for hematopoietic reconstitution on a per-cell
basis appeared to be normal (M.T. et al., unpublishedother’s function (Ouyang et al., 1998).
Given that (1) GATA-3 is expressed by early lympho- data).
B and NK cells, but not T cells, were generated fromcyte precursors (CLP, NKP), (2) T and NK cells share a
common NK/T bipotent in fetal thymus, (3) GATA-3 plays GATA-3 FL-derived HSC chimeras, confirming our re-
sults using AGM-derived HSC. Splenic B cell phenotypean essential role in T cell specification, and (4) GATA-3
promotes cytokine-specialization in T cells, we decided and absolute numbers were comparable in both types
of chimeras (Figures 1A and 1B; data not shown). Splenicto investigate the effects of GATA-3 disruption on NK
cell development. Here we present evidence for the par- NK cells were about 1.4-fold reduced in absolute num-
bers (wt: 0.88  0.54  106 cells versus GATA-3: 0.61 ticipation of GATA-3 in multiple aspects of NK cell differ-
entiation, such as maturation, homing to the liver, and, 0.24  106 cells; n  14 for each genotype; p  0.043;
Figures 1A and 1B), but expressed normal levels ofparadoxically, IFN- production.
NK1.1, DX5, CD2, 2B4, and the IL-2R chain (Figure 1C).
Results
NK Cell Cytotoxicity in GATA-3 NK Cells
The capacity of NK cells to lyse susceptible target isGATA-3 Is Dispensable for NK Cell Development
GATA-3 is expressed in the developing nervous system, the best-characterized effector function of this class of
innate lymphocytes (reviewed in Trinchieri, 1989). Weand in distinct hematopoietic lineages, including early
hematopoietic precursors, and immature and mature assessed whether GATA-3 was required for normal un-
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Table 1. Genotype Distribution of Embryos Derived from GATA-3/ Intercrosses
No. of No. of No. of Viable No. of Nonviable No. of Viable No. of GATA-3
Litters Embryos Control Embryos GATA-3 Embryos GATA-3 Embryos Chimeras
AGM (E10.5) 34 231 189 (81.8%) 5 (2.2%) 37 (16%) 9
FL (E12.5) 2 15 13 2 (13%) 0 (0%) NA
FL-DOPA (E12.5) 84 513 410 (80%) 71 (13.8%) 32 (6.2%) 16
Aorta-gonad-mesonephros (AGM) regions were isolated from embryonic day 10.5 (E10.5) fetuses, whereas fetal livers were harvested at E12.5
from DOPA-treated females. GATA-3 embryos were obtained at lower than expected frequency at both developmental time window (16%
at D10.5; 6.2% at E12.5). Without DOPA treatment, no viable GATA-3 fetuses were recovered at E12.5 (Lim et al., 2000).
folding of the cytolytic program. Splenic NK cells from GATA-3-Deficient Chimeras Are Susceptible
to L. monocytogenes Infectioncontrol and GATA-3 chimeras showed similar cytolytic
capacity, and both demonstrated a lytic potential that GATA-3 initiates and maintains T helper 2-type (Type 2)
cytokine production (Glimcher and Murphy, 2000; Howas greater than that observed in nonreconstituted
Ragc hosts (Figure 2A and data not shown). NK cyto- and Glimcher, 2002). However, ectopic expression of
GATA-3 in developing Th1 cells results in decreasedtoxicity can be potentiated by IL-12 stimulation which
acts through constitutively expressed IL-12 receptors IFN- production (Ferber et al., 1999; Ouyang et al.,
1998; Lee et al., 2000; Usui et al., 2003), as GATA-3 canon NK cells (Kobayashi et al., 1989). Accordingly, over-
night stimulation of wt and GATA-3 splenocytes with antagonize T-bet, an essential transcription factor for
Th1 development and IFN- production in CD4 T andIL-12 enhanced the lytic capacity of both types of NK
cells (Figure 2B). These observations suggest that NK NK cells (Szabo et al., 2000, 2002). We hypothesized that
GATA-3 deficiency in NK cells could potentially result incells developing in the absence of GATA-3 have normal
cell-mediated killing and express functional receptors enhanced Th1-type IFN- production.
NK cell-derived IFN- has been shown to be particu-for IL-12.
Figure 1. Lymphoid Reconstitution in HSC Chimeras
FL-derived HSC were transferred into alymphoid mice (Ragc) to generate hematopoietic chimeras.
(A) Flow cytometric analysis of splenocytes stained for B (CD19) and T (CD3) cells. NK cells (NK1.1 IL2R) were detected in the
CD19CD3 fraction.
(B) Absolute numbers of NK cells (CD3NK1.1IL-2R) and B cells (CD19) in control C57Bl/6 (black circles, n  14) and GATA-3 (gray
circles, n  16) chimeras. The mean values are represented by a gray bar. There is a significant decrease in splenic NK cells (p  0.04) and
no difference in B cells in the absence of GATA-3.




Figure 3. GATA-3 Chimeras Fail to Control Early Listeria Infection
Nonreconstituted Ragc mice or CD3	 or GATA-3 chimeras
Figure 2. Natural Cytotoxicity in the Absence of GATA-3 (groups of 4 to 5 mice) were infected intravenously with 2  103
(A) Freshly isolated splenocytes from control C57Bl/6 (black) and colony forming units (CFU) of the L. monocytogenes strain LO29
GATA-3 (gray) chimeras showed similar lytic activity against 51Cr- (Bregenholt et al., 2001).
labeled YAC-1 target cells. Indicated numbers of NK cells were (A) Serum IFN- levels were measured 2 days postinfection using
added per well as determined by parallel flow cytometric analysis. a cytokine-specific sandwich ELISA.
One representative experiment of four is shown. (B) Bacterial burden in the spleen and liver of infected mice were
(B) Control C57Bl/6 (black) and GATA-3 (gray) splenocytes were enumerated 4 days postinfection. One representative experiment
stimulated for 16 hr with IL-2 alone (circles) or in combination with of two is shown.
IL-12 (squares) prior to analysis of lytic activity against YAC-1 target
cells. One representative experiment of two is shown.
In order to appropriately control for the T cell-defi-
ciency in GATA-3 chimeras, we compared their anti-
listeria responses to chimeras generated using CD3	larly important in protecting the host early in the course
of infection by viruses or intracellular bacteria (reviewed HSC, which like GATA-3 chimeras generate B and NK
cells but no T cells (Malissen et al., 1995). Control micein Biron et al., 1999). We utilized the well-characterized
mouse model of infection by the obligate intracellular included nonreconstituted Ragc hosts, which are
highly susceptible to L. monocytogenes infection, andbacterium Listeria monocytogenes. Early control of in-
fection by L. monocyogenes can be achieved in the CD3	mice, which control early infections (Renard et al.,
1995). Surprisingly, GATA-3 chimeras were markedlyabsence of B and T lymphocytes as evidenced by sev-
eral studies in Rag and SCID mouse strains (reviewed defective in their capacity to control infection by L.
monocytogenes with reduced serum IFN- levels (3-foldin Unanue, 1997). In this situation, early antibacterial
control is abolished by depletion of NK cells or by admin- reduced), which was only marginally above the baseline
found in infected control Ragc recipients (Figure 3A).istration of antibodies against IL-12 or IFN-. The current
model proposes that macrophage or dendritic cell- This was paradoxical, since the absence of GATA-3
might act to de-repress IFN- production. The bacterialderived IL-12 stimulates NK cell-derived IFN-; the latter
appears crucial to generate activated macrophages burden was significantly increased in GATA-3 chimeras
compared to CD3	 controls (Figure 3B) and appearedwhich limit the infection prior to establishing adaptive
immunity. more pronounced in the liver compared with the spleen,
Multiple Roles for GATA-3 in NK Differentiation
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Figure 4. GATA-3 NK Cell Are Poor Producers of IFN-
(A) Polarized murine Th1 and Th2 clones (stimulated with phorbol ester and ionomycin) or splenocytes from control or GATA-3 chimeras
(stimulated for 16 hr with a combination of IL-2/12/18) were analyzed for intracellular IFN- or IL-13. For NK cells, analysis was performed on
electronically gated CD3NK1.1 cells. One representative experiment of six is shown.
(B) Splenic NK cells from control (in this case, CD3	) or GATA-3 chimeras were stimulated for 24 hr with IL-2 and IL-12, IL-18, IL-1218 (2 
104 cells) or with mAb against CD11b or 2B4 (104 cells) and IFN- release measured by ELISA. Significantly more IFN- was released in
response to IL-1218 compared to IL-12 alone (p 
 0.05).
(C) Semiquantitative PCR analysis of T-bet and Hlx expression in sorted splenic NK cells (CD3NK1.1IL-2R) from control or GATA-3
chimeras. Two-fold dilutions of cDNA were tested as well as HPRT levels to control for integrity and quantity of the input cDNA.
where 100-fold and 7.5-fold more bacteria were recov- defect in IFN- production by GATA-3 NK cells upon
IL-12, IL-18, or IL-12/18 stimulation was confirmed byered, respectively (Figure 3B). These results demon-
strate that GATA-3 is required for the early protective ELISA (Figure 4B); IFN- levels were also markedly di-
minished after stimulation of GATA-3 NK cells by cross-NK cell response against L. monocytogenes.
linking different cell surface receptors, including CD11b
or the 2B4 molecule, both of which induce IFN- produc-GATA-3 NK Cells Have an Intrinsic Defect
in IFN- Production tion by control NK cells (Figure 4B). We failed to detect
IL-5 production by NK cells under any stimulation condi-We next analyzed cytokine production by wt and
GATA-3 NK cells. Murine NK cells may produce either tions (data not shown). Collectively, these results dem-
onstrate an intrinsic defect in NK cell IFN- production“Type 1” (IFN-) or “Type 2” (IL-5, IL-13) cytokines after
appropriate monokine stimulation (reviewed in Colucci in the absence of GATA-3.
We next analyzed the expression of transcription fac-et al., 2003). We first established intracellular staining
conditions for detection of IFN- or IL-13 using Th1- or tors known to control IFN- production in T and NK
cells. T-bet acts to establish an active chromatin config-Th2-polarized T cell clones (Figure 4A). Next, freshly
isolated splenic NK cells were stimulated using different uration of the IFN- locus (Murphy and Reiner, 2002),
and its expression is induced in T cells and NK cells bycombinations of IL-2, -12, and/or –18, and intracellular
cytokines were assessed. Control NK cells produced soluble factors, including IL-12 and IL-18 (Szabo et al.,
2000). T-bet cooperates with the homeobox factor Hlx,high levels of IFN- in response to stimulation; in con-
trast, GATA-3 NK cells were poor IFN- producers, which is broadly expressed in multiple hematopoietic
cell lineages, including NK cells, to upregulate IFN-demonstrating about a 4-fold decrease in the frequency
of IFN- NK cells with a 2-fold decrease in cytokine expression (Mullen et al., 2002). NK cells from wt chime-
ras expressed both T-bet and Hlx (Figure 4C). In con-staining intensity (Figure 4A). While previous reports
have documented IL-13 production by NK cells after trast, T-bet expression was approximately 4-fold re-
duced in GATA-3 NK cells compared to controls, whileIL-18 stimulation (Hoshino et al., 1999), in our hands,
intracellular IL-13 was under the detection limit from Hlx expression was about 10-fold reduced (Figure 4C).
Expression of Id2, an inhibitor of bHLH transcriptionsimilarly stimulated splenic NK cells (Figure 4A). The
Immunity
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Figure 5. Peripheral GATA-3 NK Cells Have
an Immature Phenotype
(A) Expression of CD11b, CD43, and B220
on splenic CD3IL-2RNK1.1 NK cells from
CD3	 and GATA-3 chimeras. Percentages
of positive cells are indicated.
(B) Expression of CD11b and CD43 on bone
marrow CD3IL-2RNK1.1 NK cells from
CD3	 and GATA-3 chimeras. Percentages
of positive cells are indicated.
(C) Expression of CD94, Ly49D, Ly49C/I,
Ly49G2, and KLRG-1 on splenic CD3IL-
2RNK1.1 NK cells from CD3	 and GATA-
3 chimeras. Percentages of positive cells
are indicated.
factors required for NK development (Yokota et al., 1999) and splenic NK cells from GATA-3 chimeras appeared
similar with respect to CD11b and CD43 expression.was similar in control and GATA-3 NK cells. The com-
As such, BM and splenic GATA-3 NK cells resembledbined deficiency in T-bet and Hlx expression may ex-
immature BM NK cells from control chimeras (Figure 5B).plain the poor inducible IFN- production in NK cells
NK cells express a “repertoire” of receptors, includingthat develop without GATA-3.
the lectin-like CD94 molecule which complexes with
NKG2ACE, as well as various activating and inhibitory
NK Cells that Develop in the Absence of GATA-3 members of the Ly49 gene family (reviewed in Lanier,
Have an Immature Phenotype 1998). Previous studies have suggested that the NK
We further characterized the BM and splenic NK cell repertoire is acquired sequentially during development
phenotype in control (B6 or CD3	) versus GATA-3 chi- in the bone marrow, with CD94/NKG2ACE appearing
meras. Control splenic NK cells expressed higher levels first and then giving way to Ly49 expression (reviewed
of CD11b and CD43 compared with their GATA-3 coun- in Raulet et al., 2001). As shown in Figure 5C, we found
terparts (Figure 5A). In addition, B220 expression was that GATA-3 splenic NK cells expressed an abnor-
different in GATA-3NK cells, with a more homogeneous mal repertoire of MHC binding receptors. The CD94/
expression compared with the broad expression profile NKG2ACE complex was clearly overexpressed (control:
in control NK cells. Recently, CD11b and CD43 expres- 58% versus GATA-3: 80%, p  0.0027), whereas NK
sion was shown to be regulated during NK cell matura- cells expressed normal levels and percentages of
tion, being higher in the splenic and lower in BM NK Ly49G2. In contrast, Ly49A, Ly49C/I, and Ly49D were
cells (Kim et al., 2002). We confirmed this finding in significantly underrepresented (2- to 3-fold; p  0.003).
Finally, expression of KLRG-1 (also known as Mast cellcontrol chimeras (Figure 5B), and observed that both BM
Multiple Roles for GATA-3 in NK Differentiation
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Figure 6. Selective Deficiency of Liver NK Cells in GATA-3 Chimeras
(A) Absolute number of hepatic and bone marrow NK cells in control C57Bl/6 (black circles; n  14) and GATA-3 (gray circles; n  16)
chimeras. There is a highly significant decrease in liver NK cells (p  2.3  105) and a significant increase in BM NK cells (p  0.002) in the
absence of GATA-3.
(B) Expression of indicated adhesion molecules on splenic CD3IL-2RNK1.1 NK cells from control C57Bl/6 (shaded histograms) and GATA-3
(bold line) chimeras.
(C) Bone marrow from CD3	 and GATA-3 chimeras was labeled with CFSE and injected in Ragc mice. The percentage of CD3	 or GATA-3
NK cells among CFSE cells identified in the spleen or liver 15 hr after injection is indicated. Significantly fewer liver NK cells are recovered
from GATA-3 BM transfers (p 
 0.05). One representative mouse of six (for each genotype) is shown.
function-associated antigen or MAFA), a recently identi- from control and GATA-3 chimeras (Figure 6B and data
not shown). Expression levels of CD11c and CD49d werefied NK cell lectin-like inhibitory receptor (Hanke et al.,
1998), was also reduced on splenic NK cells in the ab- reduced in GATA-3 NK cells from BM, spleen, and liver,
whereas CD62L expression was increased. There wassence of GATA-3 (Figure 5C).
no difference in CD11a and CD54 expression between
control and GATA-3 splenic NK cells (Figure 6B).Hepatic NK Cells Are Selectively Reduced
in the Absence of GATA-3 We hypothesized that GATA-3 NK cells might be un-
able to normally home from the BM to the liver. Consis-As we observed a higher bacterial burden in the liver
of GATA-3 chimeras after L. monocytogenes infection tent with this hypothesis, absolute numbers of NK cells
in the bone marrow of GATA-3 chimeras were increased(Figure 3B), we further investigated the effects of GATA-
3-deficiency on the development of liver NK cells (Figure (control: 128,000  85,000 cells versus GATA-3:
270,000  122,000 cells, p  0.003; Figure 6A). We next6A). Interestingly, steady-state levels of hepatic NK cells
were significantly reduced (6-fold) in GATA-3 chimeras performed adoptive transfer experiments to assess BM
NK cell homing to the spleen and liver. For this purpose,(control: 56,000  36,000 cells versus GATA-3: 9,000 
6,000 cells, p  2.2  105). The residual hepatic and we labeled total BM cells from GATA-3 or CD3	 chime-
ras with the vital dye CFSE, and injected them into NK-splenic NK cells in GATA-3 chimeras had a normal mito-
chondrial membrane potential (Joza et al., 2001), sug- deficient Ragc hosts. We analyzed the absolute num-
bers of CFSE NK cells recovered from the spleen andgesting that GATA-3 NK cells had not entered into the
apoptotic process (data not shown). The reduction in liver 15 hr after transfer to limit the potential effects
of homeostatic expansion and/or NK cell recirculationresident hepatic NK cells provides a potential cause for
the increased sensitivity of this tissue to L. monocyto- (Ranson et al., 2003). As shown in Figure 6C, control
and GATA-3 BM NK cells homed equally well to thegenes.
The reduction in liver NK cells in GATA-3 chimeras spleen of recipient mice (control: 2.3  0.8% versus
GATA-3: 2.1  0.7%; n  6 mice each genotype). Insuggests that this TF influences NK cell homeostasis.
Coordinate actions of several adhesion molecules are marked contrast, NK cell homing to the liver was clearly
defective in the absence of GATA-3, with a roughly 7-foldimplicated in the localization of lymphocytes to specific
tissues sites (reviewed in Johnston and Butcher, 2002). decrease in percentages of NK1.1CFSE cells (control:
1.5  1.0% versus GATA-3: 0.2  0.03%).We analyzed adhesion molecules expressed on NK cells
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Discussion factor that can dissociate effector functions of differenti-
ating NK cells.
GATA-3 chimeras failed to produce adequate levelsTranscription factors (TF) are required for cell type spec-
of IFN- during the early response to infection by theification in multiple tissues, including the hematopoietic
intracellular bacterium L. monocytogenes. Thus, GATA-3system. Previous studies have demonstrated a role for
paradoxically promoted the development of a prototypi-GATA-3 in early T lymphocyte determination; in the ab-
cal Type 1 cytokine (IFN-) in NK cells. However, sincesence of GATA-3, development of the T lineage is com-
GATA-3 NK cells appear immature, NK cells may ac-pletely abrogated (Ting et al., 1996). GATA-3 also plays
quire the competence to produce IFN- at a later stagean important role in later stages of T cell differentiation,
in their maturation. Inadequate serum IFN- levels haveacting to promote Type 2 cytokine production in polar-
been associated with susceptibility to listeriosis and toized T cells (Glimcher and Murphy, 2000; Ho and
increased bacterial burden in target organs, includingGlimcher, 2002). Our results highlight novel and unex-
the spleen, liver, and brain (reviewed in Unanue, 1997).pected roles for GATA-3 in NK cell differentiation. First,
Accordingly, GATA-3 chimeras were unable to provideGATA-3 is not an obligate TF for specification of NK
early anti-bacterial response after L. monocytogenescells. Second, GATA-3 acts paradoxically to promote
infection, and harbored as many bacteria as alymphoidIFN- production during NK cell differentiation. Third,
control mice. The defect in IFN- production by GATA-3GATA-3 is not required for the development of natural
NK cells was observed ex vivo following stimulation withcytotoxicity. Finally, GATA-3 NK cells do not localize
cytokines, or with crosslinking antibodies. The globalnormally to the liver.
defect in IFN- production argues against a specificPeripheral NK cells that develop in the absence of
signaling defect, but rather suggests that the IFN- pro-GATA-3 resemble immature BM NK cells (expressing
moter is less active in the GATA-3 NK cells. Molecularlow amounts of CD11b and CD43), whereas splenic NK
analysis revealed a decrease in the expression of twocells from control mice are CD11bhi and CD43hi. The
genes known to be involved in the control of IFN- pro-immature phenotype of GATA-3 NK cells is also sup-
duction: T-bet and Hlx (Mullen et al., 2002; Szabo etported by analysis of their NK receptor repertoire. NK
al., 2000). The combined defect in T-bet and Hlx mightcell activating and inhibitory receptors that are specific
dampen (but not abrogate) the capacity to producefor classical and nonclassical MHC molecules (including
IFN-. Interestingly, mice deficient in T-bet have defectsthe CD94/NKG2ACE complex and members of the Ly49
not only in IFN- production, but also in natural cytotox-family) help define the threshold required for NK cell
icity. Since the latter is conserved in GATA-3 NK cells,activation of effector functions. NK receptor acquisition
IFN- production may be more sensitive to reductionsin the mouse appears sequential, whereby the CD94/
in T-bet compared with cytotoxicity. Alternatively, theNKG2ACE complex is expressed before Ly49 molecules
NK cells in T-bet mice may be blocked at an earlier(reviewed in Raulet et al., 2001). GATA-3 NK cells in-
stage of differentiation.completely acquire NK receptors: early markers (CD94)
Our results suggest that GATA-3 plays an importantwere overrepresented, while other receptors (Ly49A,
role in early NK cell development at the transition fromC/I, D) were underrepresented. Our data suggest that
the CD11blo/CD43lo stage to the CD11bhi/CD43hi stage.GATA-3 could control the timing or accessibility of dis-
GATA-3 activity appears crucial for generation of a ma-tinct Ly49 receptor genes.
The killer cell lectin-like receptor G1 (KLRG-1, also ture cell surface phenotype, for receptor repertoire di-
versification, and for acquisition of IFN- productionknown as Mast cell function-associated antigen or MAFA)
is a novel inhibitory receptor expressed by mouse NK potential. Recently, Perussia and colleagues analyzed
an in vitro system for human NK cell differentiation andcells (Hanke et al., 1998). KLRG-1 expression appears
indirectly regulated by inhibitory Ly49/MHC interactions proposed that cytokine production profiles were devel-
opmentally controlled (Loza and Perussia, 2001). In theirvia SHP-1 signaling: strong signals through inhibitory
Ly49 receptors would favor higher KLRG-1 expression model, immature NK cells were Type 2 (IL-13-producing)
and later converted to mature NK cells with Type 1(Corral et al., 2000). Our observations that KLRG-1 ex-
pression was decreased in GATA-3NK cells are consis- (IFN-) profile. By analogy with T cells, it is possible that
these cytokine profiles would be under the control oftent with this model, since the Ly49 repertoire in the
absence of GATA-3 was clearly restricted. Alternatively, TF, including GATA-3 and T-bet, and thereby identify
stages in which these TFs are active. Whether the cyto-KLRG-1 may represent a novel marker of NK cell matura-
tion. Reduced KLRG-1 expression in immature BM NK kine profiles of murine NK cells are likewise controlled
is unknown, and is complicated by the lack of definitivecells in control mice supports this conclusion.
A recently proposed scheme of murine NK cell differ- evidence demonstrating IL-5 or IL-13 production by
mouse NK cells following stimulation ex vivo. Whetherentiation suggested that acquisition of cytotoxicity and
IFN- production were rather late events (Kim et al., GATA-3 promotes the production of other Type 2 cyto-
kines in the mouse at the immature stage remains to2002). In contrast, the immature phenotype of GATA-3
NK cells does not appear to impact on the development be tested.
We also provide evidence for a specific role of GATA-3of natural cytotoxicity. Splenic NK cells from GATA-3
chimeras kill YAC-1 targets normally and the cytotoxic in the homeostasis of hepatic NK cells. In the absence
of GATA-3, NK cells in the liver were markedly reduced.potential of GATA-3 NK cells could be enhanced by IL-
12. Therefore, cytotoxicity against YAC-1 targets can Coordinated actions between chemokines and adhe-
sion molecules are required for lymphocyte homing (re-be demonstrated in NK cells with an apparent immature
phenotype. In this way, the acquisition of natural cyto- viewed in Johnston and Butcher, 2002). Although little
is known about the signals which regulate NK homingtoxicity and of cytokine production capacities by NK
cells may be separable qualities, with GATA-3 as a key in the steady state, chemokines (including MIP-1 and
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as those deficient in Rag2 alone (Rag mice) on the C57BL/6 (B6)fractalkine) appear important in attracting NK cells to the
background have been described (Colucci et al., 2001). Mice car-liver under inflammatory conditions (reviewed in Biron et
rying an inactivated allele of GATA-3 (Pandolfi et al., 1995) wereal., 1999). However, liver NK cells are not reduced in
extensively backcrossed (12 generations) to C57Bl/6 mice. CD3	
healthy MIP-1 mice (Salazar-Mather et al., 2000). The mice (Malissen et al., 1995) were kindly provided by N. Legrand and
analysis of cell surface adhesion molecules in GATA-3 A. Freitas (Pasteur Institute, Paris). B6 mice were obtained from Iffa-
Credo (France). All mice described in this study were maintained inNK cells revealed higher levels of CD62L (L-selectin)
specific pathogen-free conditions and were used between 5 to 10and lower levels of CD11c and CD49d, suggesting an
weeks of age.impaired homing potential. Indeed, transfer studies of
Generation of hematopoietic chimeras in alymphoid Ragcmicebone marrow NK cells revealed a marked defect in hom-
on the H-2k background were performed as described (Colucci et
ing to the liver in the absence of GATA-3. In previous al., 2001) using slight modifications. GATA-3 / mice (H-2b) were
work, a dominant-negative GATA-3 transgene affected mated and the morning of vaginal plug discovery was designed as
embryonic day 0.5 (E0.5). To recover GATA-3 FL, we fed gestatingnormal homing of T cells to lymph nodes (Yamagata et
GATA-3 / females with DOPA (1 mg/ml) and ascorbic acid (0.25%;al., 2000). While a molecular mechanism was not pro-
both from Sigma, Saint Louis, Missouri) in drinking water beginningvided for this observation, the data suggest that GATA-3
at 6 days postcoitum (Lim et al., 2000). Aorta-gonad-mesonephrosmay control the capacity of T cells and NK cells to
(AGM) region or fetal liver (FL) were recovered at day E10.5 or E12.5,
distribute in a tissue-specific fashion. respectively, and GATA-3-deficient (GATA-3) embryos identified by
Along these lines, we were unable to detect immature PCR (Lim et al., 2000). Recipient mice were irradiated with 600 rads
from a cesium source and injected intravenously with 3 AGM orT cells in the thymus of GATA-3 chimeras (data not
300,000 FL cells as source of donor hematopoietic stem cells (HSC).shown), suggesting that GATA-3 may have a role in
Chimeric mice were analyzed between 6 and 9 weeks posttransfer.allowing committed early lymphoid or T cell progenitors
to home to and colonize the thymus. Early thymic pro-
Isolation of Lymphoid Cells and Flow Cytometric Analysisgenitors have the capacity to differentiate into NK, DC,
Single-cell suspensions were prepared from bone marrow, spleen,
and B cells in addition to T cells (reviewed in Rodewald, and perfused liver and stained as described (Ranson et al., 2003).
1995). Because NK cells develop in GATA-3 chimeras Monoclonal antibodies (mAb) directly conjugated to FITC, PE, biotin,
in the apparent absence of thymic seeding, our results PerC.P.Cy5, or allophycocyanin (APC) and streptavidin conjugates
were obtained from Pharmingen (San Diego, CA). Samples wereargue against an obligate pathway of NK cell differentia-
analyzed using a FACScalibur flow cytometer with Cell Quest 3.3tion from thymic progenitors. These observations are
software (Becton Dickinson, San Diego, CA). We analyzed the mito-consistent with previous reports of thymus-independent
chondrial membrane potential as a marker of apoptosis using 3,3-
pathways of NK cell development (reviewed in Colucci dihexyloxacarbocyanine iodide (DIOC6; Molecular Probes, Leiden,
et al., 2003). Netherlands) as described (Joza et al., 2001).
Several models can be proposed to explain the NK
cell phenotype that develops in the absence of GATA-3: Gene Expression Analysis
RNA was isolated from splenic NK cells (CD3IL-2RNK1.1) using(1) GATA-3 may be required for the development of a
RNABle (EUROBIO, Les Ulis, France) and cDNAs synthesized usingspecialized subset of NK cells, but would not be required
avian myeloblastosis reverse transcriptase (PROMEGA, Wisconsin),for “mainstream” NK cell differentiation. This “GATA-
primed with random hexanucleotides and oligo-dT (Amersham
3-dependent” subset could represent NK cells which Pharmacia). Semiquantitative PCR was performed on serial 2-fold
would eventually home to the liver. While this model cDNA dilutions using Taq Platinum polymerase (Invitrogen, Paisley,
could explain the observed deficiencies in hepatic NK Scotland) and 35 cycles at an annealing temperature of 60C. Primer
sequences were: 5-HPRT 5-CACAGGACTAGAACACCTGC-3, 3-cells, it does not adequately explain the broad pheno-
HPRT 5-GCTGGTGAAAAGGACCTCT-3, 5-Hlx 5-GCCTCACGtypic and functional defects observed in the majority
GATGCACAGGTGAAG-3, 3-Hlx 5-GTGGCGTCCGGCTCCAATCof splenic NK cells; (2) GATA-3 may be required for
TAG-3, 5-T-bet 5-CATCACTAAGCAAGGACGGCGA-3, 3-T-bet
development of specialized NK cell functions (notably 5-AACAGATGCGTACATGGACTCAA-3, 5-Id2 5-TCTGAGCTTAT
IFN- production); its absence would not globally affect GTCGAATGATAGC-3, and 3-Id2 5-CACAGCATTCAGTAGGCTC
NK cell differentiation but only provoke selective defi- GTGTC-3. HPRT expression was used to control quantity and integ-
rity of the cDNA preparations.ciencies due to gene-specific defects. This model could
explain the normal cytolytic capacity of GATA-3 NK
Listeria monocytogenes Infectioncells, but is at odds with their immature phenotype; and
Nonreconstituted Ragc mice CD3	 and GATA-3 chimeras were(3) a “GATA-3-dependent” stage in the BM would be
infected intravenously with 2  103 Listeria monocytogenes (refer-required for NK maturation, through which all (or most) ence strain L028) as previously described (Bregenholt et al., 2001).
NK cells must pass. During this checkpoint, NK cells At day 2, mice were bled for serum IFN- determinations and at day
would receive signals that depend on GATA-3 expres- 4, spleen and liver bacterial burdens were determined (Bregenholt
et al., 2001).sion, and would allow their further maturation in terms
of cell surface phenotype (generation of CD11bhi/CD43hi
NK Cell Functional Activitiesphenotype) and expression of molecules required for
A standard 51Cr release assay was used to measure NK lytic activityIFN- production (T-bet, Hlx) and/or tissue-specific
against YAC-1 as described (Colucci et al., 2001). Cells were culturedhoming. A variant of this model would simply require
in U-bottom microtiter plates in complete medium containing huIL-2
GATA-3 expression in developing BM NK cells for tissue- (1000 U/ml) and stimulated with mIL-12 (5 ng/ml, Peprotech, Rocky
specific homing to the liver, where further phenotypic Hill, NJ) and/or IL-18 (25 ng/ml, R&D, Minneapolis, MN) overnight.
Intracellular staining was performed as described (Ranson et al.,and functional maturation of NK cell takes place.
2003) using antibodies against IFN- (XMG1.2), IL-13 (BAF413, R&D
Minneapolis, MN), and isotype-matched controls. Intracellular stain-Experimental Procedures
ing conditions were validated using polarized Th1 (HDK1) and Th2
(D10.G4) clones (kindly provided by A. O’Garra, NIMR, London).Mice and Generation of Hematopoietic Chimeras
Mice doubly-deficient in the recombinase activating gene (Rag)-2 Cytokines released into tissue culture supernatants or in the serum
of L. monocytogenes infected mice were analyzed by cytokine-and in the common cytokine receptor  chain (Ragc mice) as well
Immunity
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specific sandwich ELISA as previously described (Bregenholt et the mouse homolog of MAFA, is modulated by MHC class I mole-
cules. Eur. J. Immunol. 30, 920–930.al., 2001).
Engel, I., and Murre, C. (2001). The function of E- and Id proteins in
NK Cell Homing Assay lymphocyte development. Nat. Rev. Immunol. 1, 193–199.
To evaluate capacity of bone marrow NK cells to home to different Ferber, I.A., Lee, H.J., Zonin, F., Heath, V., Mui, A., Arai, N., and
tissues, total bone marrow (from CD3	 and GATA-3 chimeras) was O’Garra, A. (1999). GATA-3 significantly downregulates IFN- pro-
labeled with CFSE (5- and 6-carboxyfluorescein diacetate succini- duction from developing Th1 cells in addition to inducing IL-4 and
midyl ester, Molecular Probes, Eugene, OR) at 5 M and washed IL-5 levels. Clin. Immunol. 190, 134–144.
in ice-cold PBS. Equivalent numbers of donor NK1.1 cells (3 104)
George, K.M., Leonard, M.W., Roth, M.E., Lieuw, K.H., Kioussis,were injected i.v. in nonirradiated Ragc recipients. Fifteen hours D., Grosveld, F., and Engel, J.D. (1994). Embryonic expression andafter cell transfer, recipient mice were analyzed for numbers of
cloning of the murine GATA-3 gene. Development 120, 2673–2686.CFSE NK cells in the spleen and liver.
Glimcher, L.H., and Singh, H. (1999). Transcription factors in lympho-
cyte development—T and B cells get together. Cell 96, 13–23.Statistics
Glimcher, L.H., and Murphy, K.M. (2000). Lineage commitment inData were analyzed with the Microsoft Excel software applying the
the immune system: the T helper lymphocyte grows up. Genes Dev.two-tailed Student’s T-test. The null hypothesis was rejected and
14, 1693–1711.difference assumed significant when p 
 0.05.
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